InsiderTrades

Form 4 for TWST Twist Bioscience Corp

Accepted 2022-01-20 00:00:00 ET · period of report 2022-01-18 · accession 0001214659-22-000946 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-01-20 2022-01-18 TWST Leproust Emily M. Pres, CEO, Dir M - OptEx $8.82 +286 198.9K +0.1% +$2,523
D 2022-01-20 2022-01-18 TWST Leproust Emily M. Pres, CEO, Dir F - Tax $77.39 -579 198.0K -0.3% -$44.8K
D 2022-01-20 2022-01-18 TWST Leproust Emily M. Pres, CEO, Dir S - Sale+OE $60.03 -286 198.6K -0.1% -$17.2K
D 2022-01-20 2022-01-18 TWST Leproust Emily M. Pres, CEO, Dir M - OptEx $0.00 +286 150.9K +0.2% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-01-18 M A 286 $8.82 198,875 D — —
2 Common Common Stock 2022-01-18 F D 579 $77.39 198,010 D — — (F3) Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
3 Common Common Stock 2022-01-18 S D 286 $60.03 198,589 D — — (F2) Represents the weighted average sales price per share. The shares sold at prices ranging from $60.00 to $60.13 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
4 Derivative Employee Stock Option (right to buy) 2022-01-18 M A 286 $0.00 150,879 D $8.82 · — to 2027-09-28 286 Common Stock (F5) The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.